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Abstract  Objective: To measure the prevalence of Trichomonas vaginalis (T. vaginalis) 
based on clinical manifestations and polymerase chain reaction (PCR) among 
reproductive women.
 Methods: Subjects of the study were the vaginal swab obtained from 
reproductive women who attended the gynecology examination at 
Kandanghaur and Sindang primary health care of Indramayu District, West 
Java in 2016. This study was a descriptive study with cross-sectional method. 
Sampling was performed with total sampling method and 76 of vaginal swabs 
were included in this study. The prevalence of T. vaginalis was measured 
using PCR. The vaginal specimens were collected and then processed for PCR 
analysis using TVK3/TVK7.  Results: Prevalence of T. vaginalis among reproductive women in Indramayu 
District, West Java that analyzed using PCR was 0%. This result could be 
affected by the study setting in community, presence or absence of symptoms, 
and population studied. Conclusions: There were no positive results of T. vaginalis, suggested by the 
samples that obtained from community-based of a low-risked population. 
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Introduction
Trichomonas vaginalis (T. vaginalis) is a 
flagellated protozoa known as the most 
common human parasite that responsible 
for sexually transmitted infection (STI) in the 
world.1–5 World Health Organization (WHO) 
estimated that there were 170–190 million cases of T. vaginalis infection worldwide 
each year and nearly 90% of these infections 
occur in resource-limited settings country.1,2,4 
According to WHO estimation, the prevalence 
of T. vaginalis infection in women between the 
ages of 15 and 49 in 2008 were 22% in America, 
20.2% in Africa, 8% in Eastern Mediterranean, 
5.8% in Europe, 5.7% in Western Pacific, and 
5.6% in Southeast Asia.6 The prevalence of the 
T. vaginalis infection in Indonesia had not been 
clearly studied. However, a study showed that 
the prevalence of T. vaginalis among female 
workers in Kupang, Nusa Tenggara Timur 
Province was 5%.7
The trichomonas vaginalis infection or 
trichomoniasis among women has been 
associated with mild to severe reproductive 
health outcomes including vaginitis, cervicitis, 
urethritis, low birth weight, premature 
rupture of membranes, pre-term delivery, and 
pelvic inflammatory disease.3,4 Trichomoniasis 
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including increased risk of HIV acquisition, 
increased risk of cervical cancer, and shedding 
of herpes simplex virus-2 (HSV-2) in the 
genital tract of women, which could result in 
increased transmission of other STIs.1,3,4 While 
73% of women infected with T. vaginalis are 
asymptomatic, one-third of them became 
symptomatic within six months.3 In women 
who have symptoms, usually the symptoms are 
similar to other STIs, include vaginal discharge 
which is often malodorous and yellow-green 
colour, dysuria, itching, vulvar irritation, and 
abdominal pain.1,8 However, trichomoniasis 
has specific symptoms that only occurred 
in 2–5% of women, known as “strawberry 
cervix”, as well as frothy vaginal discharge in 
12% of women with trichomoniasis.8 
There are several methods to identify T. 
vaginalis include wet mount microscopy, 
culture, and nucleic acid amplifications Tests 
(NAATs).9 Wet mount microscopy method 
has low sensitivity, which ranges from 44% 
to 68% and requires trained microscopist.10 
The sensitivity can dramatically reduce 
if there was a delay as short as 10–30 
minutes between collection and microscopic 
examination.10 Meanwhile, culture method 
provides sensitivity that ranges from 44–75% 
but needs daily examination by a trained 
microscopist and the final result may take up 
to a week.10 Both wet mount microscopy and 
culture method, require specimen handling, 
processing, and transport conditions to 
preserve viable, motile organism.10 In contrast 
with NAATs method, polymerase chain 
reaction (PCR) is one of the NAATs method 
using replication and amplification technique 
from specific individual deoxyribonucleic acid 
(DNA) target sequences. Thus, the sensitivity 
of NAATs is inherently greater than other 
methods ranges from 76–100%.10 Primer 
sets TVK3/TVK7 known as the most sensitive 
primer among others primer sets to identify 
T. vaginalis because the target of this primer 
is a repetitive DNA fragment that improve the 
detection level and produce positive results on 
specimens from asymptomatic women.11
The prevalence of T. vaginalis has been 
found to vary according to geographical 
location, study setting (sexual health clinic or 
community setting), the presence or absence of 
symptoms, population studied (ethnic group, 
age, and sex), and the diagnostic techniques used.7 This study identified T. vaginalis from 
reproductive women using vaginal swab as the 
specimen and PCR method with TVK3/TVK7 
as the primer sets.
Methods
This was a descriptive study with cross-
sectional method. Subjects of the study were 
the vaginal swab obtained from reproductive 
women who attended gynecology examination 
at Kandanghaur and Sindang primary 
health care of Indramayu District, West Java, 
Indonesia, in 2016 by total sampling.
Inclusion criteria for this study were 
vaginal swab from women with positive 
visual inspection with acetic acid (VIA) test, 
or women with vaginal discharge, or women 
with vaginal discharge with itching, or women 
with malodorous vaginal discharge. Exclusion 
criteria was the volume of the vaginal swab 
which less than 5μl. 
The vaginal swab had already been obtained 
in year 2016 and stored in -20 OC for long-term 
examination. Therefore, samples used in this 
study were stored biological material, thus 
the informed consent was unnecessary. The 
extracted genomic DNA samples underwent 
PCR and electrophoresis at the Microbiology and Molecular Laboratory of Faculty of 
Medicine, Universitas Padjadjaran, Bandung, 
Indonesia. The PCR kit consist of, primer sets 
TVK3/TVK7 and KAPA Taq Extra HotStart 
ReadyMix PCR kit®. The electrophoresis kit 
consist of peqGREEN DNA and RNA Dye®.
The PCR master mix was made according to 
the procedures provided by manufacturer. The 
initial reaction for PCR was performed at 95 OC 
for 5 minutes and then repeated 35 cycles of 
30 sec at 95 OC, 30 sec at 57.4 OC, 2 minutes at 72 OC, finally additional extensions were done at 72 OC for 7 minutes and hold at 4 OC. 
Upon completion of PCR, an aliquot was 
analyzed by electrophoresis in a 3% agarose 
gel in TAE buffer. The gel was stained with 
peqGREEN DNA and RNA dye® and was 
photographed under short ultraviolet light. 
The primer sets TVK3/TVK7 specifically 
amplify a 300 bp fragment of T. vaginalis 
genome.11 The size of amplified products was 
assessed by comparison with a commercial 
weight marker (1Kb ladder).
Positive and negative controls were 
included in all PCR runs. The DNA extract from 
motile T. vaginalis in wet mount examination 
was used as a positive control. The negative 
control consisted of PCR master mix without 
DNA. This study was approved through the 
ethical clearance number 595/UN6.KEP/
EC/2018 by the Health Research Ethic 
Committee, Faculty of Medicine, Universitas 
Padjadjaran, Bandung.
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Table 1 Characteristics of the Subjects 
Characteristics Frequency (n)
PCR Positive of T. vaginalis
Frequency (n) Percent (%)Age    20–29  years old 9 0 0
   30–39  years old 42 0 0   40–49 years old 24 0 0   50–59 years old 1 0 0Marital status   Yes 76 0 0
   No 0 0 0
Obstetrical status
   P0A0 5 0 0
   P1A0 23 0 0
   P1A1 3 0 0
   P1A3 1 0 0
   P2A0 17 0 0
   P2A1 7 0 0
   P3A0 9 0 0
   P3A2 2 0 0
   P4A0 3 0 0
   P4A1 1 0 0
   P4A2 1 0 0
   P4A4 1 0 0
   P5A0 1 0 0
   P5A1 1 0 0
Education level
   Uneducated 2 0 0
Elementary school 28 0 0Junior high school 24 0 0Senior high school 16 0 0
Diploma 2 0 0Bachelor 4 0 0
Occupation
Housewife 68 0 0
Farmer 5 0 0
   Government officer 1 0 0
Midwifery 1 0 0
Nurse 1 0 0 
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Results
During the gynecology examination at 
Kandanghaur and Sindang primary healthcare 
in 2016, from 147 women attended, 143 
vaginal swabs were obtained, and 76 samples 
were stored in laboratory and underwent PCR 
examination for this study, while the rest of 
the samples could not be extracted because of 
the volume less than 5μl. The characteristics of 
subjects which vaginal swab underwent PCR 
were described (Table 1). The prevalence of T. 
vaginalis based on PCR were shown. Based on 
these data, the PCR results of T. vaginalis were 
negative in all samples.
The prevalence of T. vaginalis based on 
clinical manifestation was shown (Table 
2). From this data, in some subjects who 
had one symptom or more, the PCR results 
were negative for T. vaginalis.
Result of electrophoresis was revealed 
(Fig. a–b). In all of the electrophoresis 
results, there was the positive control that 
has length 300kbp appropriate for the size 
of the DNA that amplified by TVK/TVK7 
primer sets, but none of the samples have a 
positive result because there was no band 
appeared in all of the results.
Discussion
The prevalence of trichomoniasis reported 
in this study was 0% using PCR method (Fig. 
a–b). The socio-demographic characteristics 
and clinical manifestation of the study 
population may affect this finding.12 The socio-
demographic characteristics of the study 
population are portrayed (Table 1). Among 
76 women who examined for T. vaginalis, 
:9–15
Electrophoresis Sample 1–12 (a), Electrophoresis Sample 13–24 (b), 
Electrophoresis Sample 25–28 (c), Electrophoresis Sample 65–76
Fig. 
a  b  
c  d  
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42 women in this study belonged to the age 
group of 30–39 years, but none of them were 
positive for T. vaginalis infection. This result 
was similar to several previous studies which 
majority of infected women were between the 
ages of 35–40 years, 26–35 years (37.93%), 
and 21–45 years (76%), respectively.6,8,12 
Unlike other nonviral STIs, trichomoniasis 
does not primarily reach young women 
(15–25 years old). It affects women during 
reproductive years, and high rates of infection 
are found in women between the ages of 35 
and 40. Predisposing factors comprise of 
older age, use of oral contraceptives, trading 
sex, smoking, single marital status, and low 
socioeconomic class.6
Other socio-demographic factors for 
trichomoniasis are marital status and 
obstetrical status. All women in this study 
have the same marital status, while obstetrical 
status varied and the result was 17 women 
(22.36%) had history of abortion. This result 
was in contrast to a study which reported 
women who have abortion previously will have 
a higher prevalence of T. vaginalis infection.13 
Both occupation and education level are 
predisposing factors for trichomoniasis in 
published literature. In the previous study, 
majority of those with trichomoniasis were 
unemployed and has less education level.12 
However, in this study, there was no difference 
between the occupation and education level 
with T. vaginalis infection.
The overall prevalence of T. vaginalis 
identification using PCR method was 0%. A 
previous study identified T. vaginalis with the 
same method as in this study which found 
the prevalence of the infection was 30%.8 The 
negative findings of T. vaginalis in this study 
could be affected by samples that obtained 
from low-risked women and the study setting 
was community-based study. In contrary, 
in clinic-based studies there was a higher 
prevalence than community-based studies. In 
community-based study, the prevalence was 
1% and 0.6% respectively. While in clinic-
based study, the prevalence was 4.4% and 4.2% 
respectively.14 Another risk factor associated 
with trichomoniasis was the last sexual 
intercourse. Therefore, the normal incubation 
period for trichomoniasis is 4–28 days. If 
the patients are infected by trichomoniasis, 
the patients are expected to be symptomatic 
within this period or immediately after. This 
may explain the lower risk of finding in those 
who had sexual intercourse over 30 days in 
:9–15
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Table 2 Prevalence of T. vaginalis Based on Clinical Manifestation
Characteristics Frequency (n)
PCR Positive of T. vaginalis
Frequency (n) Percent (%)Vaginal bleeding   Yes 1 0 0
   No 75 0 0Vaginal discharge   Yes 24 0 0
   No 52 0 0
Vaginal discharge with itching   Yes 19 0 0
   No 57 0 0
Malodorous vaginal discharge   Yes 10 0 0
   No 66 0 0VIA test
   Positive 15 0 0
   Negative 61 0 0 
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advance.12 In this study, there were no data 
about last sexual intercourse. 
The clinical manifestations varied among 
the 76 women, 52 women had no vaginal 
discharge, 57 women had no vaginal discharge 
with itching, 66 had no malodorous vaginal 
discharge, and 61 women had no cervicitis, 
indicated by negative VIA test. Most of 
women are asymptomatic but none of them 
had positive result for T. vaginalis. It is very 
difficult to predict the T. vaginalis infection 
only on clinical findings, compare to previous 
study in Belgium, 50% of the patient had 
normal vaginal findings and 20% of them were 
positive for trichomoniasis. While 36% of the 
patient had cervicitis and 44% of them were 
positive for trichomoniasis.8
This study was used PCR method to detect 
T. vaginalis since it offers an advantage of 
extreme sensitivity and ability to detect 
nonviable organisms.8 Since most cases of 
trichomoniasis are asymptomatic and the 
infection could cause serious complication 
such as HIV, cervical cancer, HSV-2, and other STIs.1,3,4 Thus, it is important to screen T. 
vaginalis infection in low-risked women to 
prevent it complications.
Moreover, diagnosis of trichomoniasis 
cannot be made solely on the basis of clinical 
presentation because the clinical symptom 
may be synonymous with those of other STIs, 
the specific symptom like strawberry cervix is 
seen approximately 2% of patients, and frothy 
discharge is seen only in 12% of women with 
trichomoniasis. It has been demonstrated that if these classical features are used alone 
in the diagnosis of trichomoniasis, 88% of 
these cases will not be diagnosed and 29% 
of uninfected women will be falsely indicated 
as having T. vaginalis infection. This suggests 
that clinical manifestation are not reliable 
diagnostic parameters and hence laboratory diagnosis is necessary for early and accurate diagnosis.8
This study had limitations such as the 
examination only covered the low-risked 
women and the study settings was a 
community-based study. Therefore, a further study can be conducted by using a broader 
population including high-risk subject.
In conclusion, the prevalence of T. vaginalis 
based on clinical manifestation and PCR among 
reproductive women in this study was 0%. 
However, the samples that obtained and stored 
from 2 years ago have a limited possibility to 
become contaminated because the samples 
already been extracted into DNA and stored in -20 OC. It was proven from the positive control 
that appeared in each electrophoresis results. 
The positive control used in this study was also 
obtained 2 years ago from motile T. vaginalis 
that underwent DNA extraction and stored 
together with other samples. 
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